These studies indicate that c‐MYC significantly participates in the glutamine metabolism, supporting our finding that LINC01764 upregulates c‐MYC and promotes cell proliferation, migration, and attenuates 5‐FU resistance in CRC cells by regulating glutamine metabolism. The gene discussed is MYC; the disease is colorectal carcinoma.